DEF 14A: Applied DNA Sciences Sets Date for 2024 Annual Stockholders Meeting, Proposes Reverse Stock Split

Applied DNA Sciences will hold its 2024 Annual Meeting of Stockholders virtually on September 30, 2024, to vote on director elections, auditor ratification, a potential reverse stock split, and warrant exercises.

Summary

• Applied DNA Sciences, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on September 30, 2024, at 10:00 a.m. Eastern Time.
• Stockholders of record as of August 1, 2024, are entitled to vote.
• The meeting will address the election of six directors, ratification of Marcum LLP as the independent registered public accounting firm, and a proposal to grant the Board of Directors discretionary authority to enact a reverse stock split within a range of one-for-five to one-for-fifty.
• Additionally, stockholders will vote on approving the exercisability of certain common stock purchase warrants issued in connection with a May 28, 2024, securities offering.
• The Board of Directors recommends voting in favor of all proposals.
• The company is using the Notice and Access method for providing proxy materials, with the mailing of the Notice of Availability of Proxy Materials scheduled to begin on or about August 21, 2024.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting necessary information for the annual meeting. The reverse stock split proposal suggests some financial challenges, but the overall sentiment is stable and focused on compliance and governance.

Positives

• The virtual meeting format is expected to increase stockholder attendance and participation.
• The Board of Directors believes that the reverse stock split is the best option available to the Company to increase its stock price as required for continued listing on Nasdaq.
• The Board believes a higher stock price may help generate investor interest in the Company and help the Company attract and retain employees.
• If the Reverse Stock Split successfully increases the per share price of the Common Stock, the Board believes this increase may increase trading volume in the Common Stock and facilitate future financings by the Company.

Negatives

• The company received a deficiency letter from Nasdaq on July 12, 2024, notifying the Company that it was not in compliance with the Minimum Bid Price Requirement.
• The Series Warrants also contain a provision requiring the Company to effect a reverse stock split in the event it receives notice from the Listing Qualifications Department of Nasdaq that it is not in compliance with the Minimum Bid Price Requirement, prior to the effectiveness of any delisting notice issued by Nasdaq.
• The Series Warrants include a provision that, conditioned upon the receipt of Warrant Stockholder Approval as more fully described in Proposal No. 4, resets their respective exercise price in the event of a reverse split of Common Stock, to the lesser of (i) the then exercise price and (ii) lowest daily volume weighted average price (VWAP) during the period commencing five trading days immediately preceding and the five trading days commencing on the date we effect a reverse stock split with a proportionate adjustment to the number of shares underlying the Series A Warrants and Series B Warrants.
• Such an exercise price reset which results in the issuances of additional shares could result in our shareholders suffering substantial dilution.

Risks

• If the company is unable to maintain compliance with the Minimum Bid Price Requirement and its Common Stock were delisted from Nasdaq, trading of its Common Stock would most likely take place on an over-thecounter market established for unlisted securities, such as the OTCQX, the OTCQB or the OTC Pink markets maintained by OTC Markets Group Inc.
• The market price of our Common Stock will also be based on and may be adversely affected by our performance, financial results market conditions, the markets perception of our business and other factors which are unrelated to the number of shares outstanding.
• If the Reverse Stock Split is effected and the market price of Common Stock declines, the percentage decline as an absolute number and as a percentage of the overall market capitalization of the Company may be greater than would occur in the absence of a Reverse Stock Split.
• Furthermore, the liquidity of Common Stock could be adversely affected by the reduced number of shares that would be outstanding after the Reverse Stock Split.

Future Outlook

The company seeks to maintain its Nasdaq listing and attract a broader range of investors through the proposed reverse stock split.

Management Comments

• James A. Hayward, Chairman, President and Chief Executive Officer, encourages stockholders to read the Proxy Statement carefully and submit their proxy or voting instructions as soon as possible.

Industry Context

The document reflects a company navigating Nasdaq listing requirements, a common concern for publicly traded companies, especially smaller ones. Reverse stock splits are a tool sometimes used to regain compliance with minimum share price requirements.

Comparison to Industry Standards

• The reverse stock split proposal is a common strategy employed by companies facing delisting from exchanges like Nasdaq; similar actions have been undertaken by companies such as Ocugen Inc. and Farmmi Inc. to maintain compliance.
• The virtual annual meeting format aligns with a growing trend among public companies to enhance accessibility and reduce costs, mirroring practices adopted by firms like Amazon and Alphabet.
• The engagement of Kingsdale Advisors for proxy solicitation is a standard practice, comparable to engagements made by companies like Tesla and GameStop to ensure sufficient stockholder participation in critical votes.

Stakeholder Impact

• Shareholders will be impacted by the decisions made at the Annual Meeting, particularly regarding the reverse stock split and warrant exercises.
• Employees may be affected by the company's ability to maintain its Nasdaq listing and attract investors.
• The company's financial stability and future prospects could impact its relationships with customers and suppliers.

Next Steps

• Stockholders need to vote on the proposals outlined in the proxy statement.
• The Board of Directors will decide whether to implement the reverse stock split and at what ratio, if approved by stockholders.
• The company will hold the Annual Meeting on September 30, 2024, and announce the voting results.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Reverse Stock Split, Director Election, Warrant Exercise, Marcum LLP, Nasdaq, Stockholders